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Hazem Kamel aa Tanta University
a EgyptIn this study we compared the real time three dimensional echocardiogram data in evaluation of patent ductus
arteriosus with the gold standard angiography.
Methods: This study included 25 patients with PDA referred to Tanta University Hospital for elective cardiac
catheterization. The patients comprised seven males and 18 females, with a mean age of 3.7 ± 0.36 years. The study
duration was six months. All patients underwent full 2D echocardiogram as well as real time three-dimensional
echocardiogram (RT3DE).
Essential measurements included the pulmonary end of the duct, duct length, aortic end and aortic ampulla as
well as the anatomical type of the PDA. Data obtained by RT3DE were compared against 2D echocardiogram and
angiography.
Results: There was no significant difference between 3D echocardiogram and angiography (P = 0.001) in the pul-
monary end of the duct measurement. Neither were there any significant differences between the length of the duct
or the aortic end measured by 3D echocardiogram and by angiography (P = 0.001 in both). While there was adequate
agreement between both 2D and 3D echocardiogram and angiography in determining the anatomical type of the
PDA, 3D echocardiogram determined type A and type E ductus more accurately than 2D echocardiogram. The fea-
sibility of Q lab analysis of PDA was 96%, while the feasibility of gated color flow 3D acquisitions in determining
anatomical types was 64%.
Conclusion: There was complete agreement on location, size, morphology and surrounding structure of PDA
between 2D and 3D echocardiogram, and angiography. This result illustrates the need for the proper placement
of the device in catheterization laboratories.
 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.
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Abbreviations
PDA patent ductus arteriosus
CHD congenital heart disease
2D two dimensional
RT3DE real time 3 dimensions echocardiography
MHz mega hertz
MPR multi plane reformatted
RAO right anterior oblique
ADO Amplatzer duct occluder
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COMPARATIVE STUDY BETWEEN REAL TIME THREE DIMENSIONAL ECHOCARDIOGRAMIntroduction
The reported incidence of patent ductus arteri-osus (PDA) varies due to methodological dif-
ferences related to the population group studied,
age of consideration, and method of detection
[1]. Although the ductus arteriosus is most often
functionally closed within 48 h of birth, some
authorities consider the patent ductus to be
abnormal only after three months of age. In chil-
dren who were born at term, the incidence of
PDA is reportedly 1 in 2000 births [1]. This
accounts for 5% to 10% of all congenital heart
diseases. However, if we include children with
‘‘silent’’ patent ductus (those discovered inciden-
tally by echocardiography performed for another
purpose), the PDA incidence is estimated to be
as high as 1 in 500 [2]. The female-to-male ratio
is 2:1 in most reports [2].
PDA occurs with increased frequency in several
genetic syndromes, including those with defined
chromosomal aberrations (such as trisomy 21
and 4p-syndrome), single-gene mutations (such
as Carpenter’s syndrome and Holt-Oram syn-
drome), and X-linked mutations (such as inconti-
nentia pigmenti) [3]. The genetic mechanism of
patent ductus in some patients may be autosomal
recessive inheritance with incomplete penetrance
[3].
Available treatment modalities include surgical
ligation in large ducts not suitable for interven-
tional treatment and transcatheter closure for
small to moderate sized ducts whether by coil
embolization or occluder devices. The accurate
assessment of the size, shape and anatomical type
of the PDA represents a crucial step to choosing
the most suitable technique to guarantee com-
plete closure of the PDA without complications
[4,5].
Two-dimensional (2D) echocardiography is an
important diagnostic tool and a mainstay for
diagnosis and evaluation prior to management.
Cardiac catheterization is also used to re-evalu-
ate the PDA prior to its percutaneous closure
[6]. With the recent introduction of 3D echocardi-
ography and its unique ability to allow real-time
volumetric imaging and thus improve the accu-
racy of evaluating cardiac chambers, the idea of
using this unique capability in interrogating
extra cardiac vascular structures like the PDA
to optimize the management seems appealing.
In this study, we compared real-time 3D echocar-
diogram data with angiography (as the gold stan-
dard) in the evaluation of patent ductus
arteriosus.Methods
This study was conducted over a period of six
months from January to June 2012, and included
25 patients with PDA who were referred to Tanta
University Hospital for percutaneous PDA clo-
sure. Full history-taking from our patients, as well
as clinical examination, 12-lead surface electrocar-
diogram (ECG), plain chest X-ray in posteroante-
rior view, and routine laboratory investigations
were made. Full echocardiographic study was car-
ried out using Philips FD 10/10 corporation cath
machine, Vingmed, Horten Norway, M4S probe
(with selection of pediatric or adult icon according
to patient’s age) for 2D and V3 matrix array trans-
ducer for 3D. This was followed by cardiac cathe-
terization (using Philips FD 10/10 cath machine)
for the evaluation of PDA type and PDA closure.
The parents of all the children were given
informed consent and acceptance to be enrolled
in the study.Echocardiography
Standard 2D echocardiogram was performed on
all patients enrolled in the study. Segmental anal-
ysis data was obtained for each patient [7]. Three
views were used in the 2D echocardiogram to
visualize the duct and its course; the high left par-
asternal or infra-clavicular view, the suprasternal
view, and the parasternal short-axis views (at the
level of great vessels). The anatomical type of
PDA was determined; the aortic end, pulmonary
end, and the length of the duct were measured.
After deployment of Amplatzer duct occluder,
echocardiography was used to assess the results
and to determine if there was any residual gradi-
ent or shunt flow through the PDA, or any newly
developed gradient across descending aorta, main
or left pulmonary artery. Echocardiography was
also used to assess accurate device position
regarding surrounding cardiac structure, or any
other complication.
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The 3D study was performed using V3 matrix
array transducer of the same Echo machine. Two
modes of acquisition were used: the narrow angle
3D imaging in all conventional 2D planes, and the
full volume with stitched four cardiac cycles, with
special emphasis on suprasternal and the left
infra-clavicular views.
Offline analysis was applied to the volume ren-
dered data. Multiplanar reformatted mode (MPR)
was used to delineate the PDA in three planes at
the same time. Each of the three planes was repre-
sented by a line in the other two planes. This line
allows movement or rotation of the plane within
the volume data. The point of intersection of the
three lines can be moved simultaneously in the
three planes to display the multiplanar projection
of the PDA. Accurate assessment of the Amplatzer
device position and its relation with the surround-
ing structure was carried out using RT3DE (Fig. 1),
as well as assessment of any residual shunt or
complications such as vegetation or thrombi on
the device.Gated color volumes
Gated color acquisition was taken to assess the
flow across the PDA and into the pulmonary
artery. The gated color flow 3D acquisition stitches
four consecutive cycles. PDA flow was acquired
from suprasternal or infra-clavicular view. GatedFigure 1. 3D Echo: Left sector (multiplanar), right sector (narrow angle vi
ductus arteriosus.color flow was useful in determining the shape
of the duct by cropping the color flow after adjust-
ment of the color gain to get the best display. The
crop box was utilized to crop the duct until the
shape of the duct appeared. We applied black
and white suppression after cropping to eliminate
the surrounding tissue and thus allow better
delineation of the duct through its course.Cardiac catheterization
We gained both arterial and venous access in all
patients using Seldinger’s technique. We admin-
istered 50 IU/kg heparin after gaining arterial
access. Using NIH or pigtail catheter, aortic angio-
gram was performed at the expected level of the
PDA. The initial angiogram was taken in the lat-
eral projection. If the lateral view showed the
PDA shape adequately, measurements were then
taken and assessment of the anatomical type was
determined based on the Krichenko classification
(Fig. 2) [8]. However, in some patients, the right
anterior oblique (RAO) 35–40 with cranial angu-
lation of 30 was needed for further evaluation of
the size and anatomical type of the PDA. We then
obtained angiographic evaluation of the pulmon-
ary end, aortic end and duct length. The duct
was measured in lateral angiogram, while the pul-
monary end was measured as the narrowest part
of the duct connected with the pulmonary artery
or its left branch. The aortic end was measured
as the widest part of the duct that connected withew) showing the Amplatzer duct occluder device (ADO I) closing the
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Figure 2. Left and right panel: Krichenko classification of anatomical types of patent ductous arteriosus.
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sured as a line from the midpoint of the pulmon-
ary end to the midpoint of the aortic end.Statistical analysis
Data were tabulated and analyzed using Version
16 of the SPSS program (Statistical Package for
Social Sciences). Qualitative data were analyzed
using frequency and percentage; quantitative data
were analyzed using mean and standard devia-
tion. Paired t-test was used to evaluate changes
in the continuous variables. P-value of <0.05 was
considered of significance. Inter-rater agreement
was applied to evaluate the agreement between
the anatomical types of the PDA determined by
2D, 3D echocardiography, or the gold standard
angiogram.Results
This study included 25 patients with PDA, seven
males (28%) and 18 females (72%), whose ages
ranged from seven months to 12 years (mean;
5.6 ± 3.9 years). The weight of the patients ranged
from seven to 23 kg (mean; 13.96 ± 4.92 kg), and
the body surface area was 0.5 to 1.1 m2 with a
mean of 0.93 ± 0.35. Two patients were asymptom-
atic, while 23 patients gave history of one or more
complaints that included dyspnea, easy fatigability,
feeding problems and/or palpitation.2D echocardiography data
Regarding the anatomical types of PDA, 16 cases
were type A (64%), one case was type B (4%), andtwo cases were type C (8%). There were no cases
of type D (0%), and six cases were type E (24%).
The pulmonary end mean diameter was
3.17 ± 1.27 mm (range 1.3–5 mm); the aortic end
mean diameter was 5.5 ± 1.3 mm (range 4–8 mm),
while the length of PDA ranged from 5 to 11 mm
with a mean of 6.99 ± 1.96. Eight patients (32%)
had dilated LV internal dimension with preserved
or even overestimated systolic function. The mean
LV end diastolic dimension was 32 + 8.43 mm
(range 20–44), while LV end systolic dimension
was 22.36 + 5.81 mm (range 15–32 mm). The inter-
ventricular septum was 4.52 + 0.98 mm (range 3–
6 mm), and the LV posterior wall was
4.01 + 1.09 mm (range 2.5–6 mm). The mean of
fraction shortening was 33.8 + 6.81% (range 24–
45%), while the ejection fraction was
65.72 + 5.56% (range 57–75%).3D echocardiography data
We used QLab analysis, which was feasible in 24
patients (96%). One patient was excluded as the
results of her image data were of poor quality. For
the remaining 24 patients, offline analysis was
implemented, and the following measurements
were obtained: pulmonary end ranged between
1.9–3.4 mm with a mean of 2.6 ± 0.61 mm; aortic
end ranged between 3.5–9 mm with a mean of
5.74 ± 1.74 mm; length of duct ranged between 4–
10 mm with a mean of 7.29 ± 1.87 mm.
Using gated color flow with black and white
suppression, we were able to assess the anatomi-
cal type of the duct in 16 cases (64%), while the
anatomical type of the remaining nine (36%) cases
could not be assessed utilizing this technique.
Table 1. The comparison between the 2D, 3D echocardiography and angiography regarding the pulmonary end of the duct.
Range PDA pulmonary end Correlations
Mean ± SD Paired test r P-value
Angio 1.2 – 4.5 2.64 ± 0.87 t P-value
2D 1.3 – 5.00 3.17 ± 1.27 Pulm. end 2D VS. angio 1.083 0.309 0.636 0.002
3D 1.9 – 3.40 2.6 ± 0.61 Pulm. end 3D VS. angio 3.721 0.000 0.756 0.001
angio
5.04.54.03.53.02.52.01.51.0
2D
6
5
4
3
2
1
Figure 3. The correlation between 2D and angiography regarding the
pulmonary end of the duct.
angio
5.04.54.03.53.02.52.01.51.0
3D
3.5
3.0
2.5
2.0
1.5
1.0
Figure 4. The correlation between 3D and angiography regarding the
pulmonary end of the duct.
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(50%), one was type B (6.25%), three were type C
(18.75%), and four were type E (25%). None of
the ducts was type D by 3D echocardiography in
our study.Angiographic data
Regarding the data obtained from the aortic
angiogram: the pulmonary end of the duct rangedbetween 1.2–4.5 mm (mean 2.64 ± 0.87 mm); the
aortic end ranged between 3–10 mm (mean
5.98 ± 1.92 mm); and the length of the duct ranged
between 4–12.5 mm (mean 7.79 ± 2.31 mm).
Lateral projection determined the anatomical
type of the duct in 14 cases (56%), while in 11 cases
(44%) the RAO cranial projection was ideal in
determining duct anatomy and type. We found
type A in 14 cases (56%), type B in one case (4%),
type C in two cases (8%), no cases of type D (0%),
and type E in eight cases (32%).
All these different anatomical types of cases were
successfully closed using Amplatzer duct occluder
I (ADO I), with no recorded complications.The pulmonary end
There was no significant difference between 2D
echocardiography and angiography in measuring
the pulmonary end using the paired t-test
(t = 1.083, P = 0.309) and thus there was positive
correlation between these two measurements
(r = 0.636, P = 0.002). In addition, there was no sig-
nificant difference between 3D echocardiography
and angiography in measuring the pulmonary
end using the paired t-test (t = 3.721, P = 0.000)
and therefore there was a positive correlation
between these two measurements (r = 0.756,
P = 0.001); (Table 1, Figs. 3 and 4).The aortic end of the duct
There was no significant difference between the
3D measurement and measurements by angiogra-
phy using the paired t-test (t = 0.574, P = 0.633).
However, there was a tendency towards underes-
timation of the aortic end by 2D echocardiography
compared to that measured by angiography
resulting in t = 2.162, P = 0.056. Both 2D and 3D
echocardiographic measurements showed a posi-
tive correlation with angiography (r = 0.613,
P = 0.002 for 2D and r = 0.748, P = 0.001 for 3D);
(Table 2, Figs. 5 and 6).The length of the duct
There were no significant differences between 3D
measurements and measurements by angiography
angio
141210864
2D
12
11
10
9
8
7
6
5
4
Figure 7. The correlation between 2D echocardiography and angi-
ography in measuring the length of the duct.
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Figure 6. The correlation between 3D echocardiography and angi-
ography in measuring the aortic end of the duct.
angio
12108642
2D
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7
6
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4
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Figure 5. The correlation between 2D echocardiography and angi-
ography in measuring the aortic end of the duct.
Table 2. The comparison between the aortic end measurement by 2D, 3D and angiography.
Range Mean ± SD Paired test Correlations
Aortic end (angio) 3 – 10 5.98 ± 1.92 t P-value r P-value
Aortic end (2D) 4 – 8 5.50 ± 1.33 AO end 2D VS. angio 2.162 0.056 0.613 0.002
Aortic end (3D) 3.5 – 9 5.74 ± 1.74 AO end 3D VS. angio 0.574 0.633 0.748 0.001
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ever, there was a tendency towards underestima-
tion of the length by 2D echocardiography
compared to that measured by angiography withTable 3. Comparison between 2D, 3D and angiographic measurem
Range Mean ± SD Paired test
Length (angio) 4–12.5 7.79 ± 2.31
Length (2D) 5–11 6.99 ± 1.96 Length 2D V
Length (3D) 4–10 7.29 ± 1.87 Length 3D Vt = 3.004, P = 0.002. Both 2D and 3D echocardio-
graphic measurements showed a positive correla-
tion with angiography (r = 0.604 and 0.693, while
P = 0.003 and 0.001, respectively); (Table 3, Figs. 7
and 8).
The anatomical type of PDA
The comparison between 2D echocardiography
and angiography in determining the anatomical
type of the duct was 21 out of 25 cases, resulting
in a total agreement of 85.7%. The comparison
between 3D echocardiography and angiography
was 13 cases out of the feasible 16 cases with an
agreement of 84.8%. Thus, the results of 2D and
3D echocardiography and angiography were com-
parable (Table 4).Discussion
Real-time 3D echocardiography (RT3DE) is
sometimes referred to as 4D, when the dimensionents of duct length.
Correlations
t P-value r P-value
S. angio 3.004 0.002 0.604 0.003
S. angio 1.005 0.317 0.693 0.001
angio
141210864
3D
10
9
8
7
6
5
4
Figure 8. The correlation between 3D echocardiography and angi-
ography in measuring the length of the duct.
Table 4. The anatomical types of the PDA by 2D, 3D
echocardiography compared with angiography.
Type 2D 3D Angio
N % N % N %
A 16 64 8 50 14 56
B 1 4 1 6.25 1 4
C 2 8 3 18.75 2 8
D 0 0.00 0 0.00 0 0.00
E 6 24 4 25 8 32
Total 25 100.00 16 100.00 25 Total
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method of accurately visualizing the dynamic
morphology of the heart. Not only does it display
moving images in 3D, but it incorporates the bio-
metric datasets frozen in time [9]. RT3DE has rev-
olutionized the clinical management of congenital
heart defects. Although most currently available
echocardiography systems come with the poten-
tial for 3D imaging, clinical utilization of RT3DE
is limited to a few centers which have developed
the expertise to implement it for surgical or trans-
catheter interventions [10]. The use of live 3D
echocardiography in congenital heart disease,
including its documented role in the assessment
of septal defects, is discussed in several studies
[11].
In the present study, we compared the real-time
three-dimensional echocardiogram data in the
evaluation of patent ductus arteriosus with the
gold standard of angiography. Our study included
25 patients for which detailed measurements of
the duct were taken by 2D and 3D echocardiogra-
phy and then compared to angiographic
measurements.
The first published report of 3D echocardio-
graphic evaluation of a PDA was by Sinha et al.
in 2004. The study reported the potential useful-
ness of real-time 3D echocardiography in comple-
ting 2D echocardiographic data in the
comprehensive assessment of patients with PDA
[12].
In 2006, Vazquez-Antona et al. published their
assessment of the ability of 3D echocardiography
to accurately view anatomic details in patients
with PDA. They studied 21 patients, 11 of whom
had their 3D echocardiography done after percu-
taneous closure, to assess the spatial relation of
the device to the surrounding anatomic structures.In ten patients, the size and morphology of the
duct was compared to 2D and 3D echocardiogra-
phy prior to closure. The authors did not include
any comparative details between the two methods
and in reviewing the literature, it appears this
study never materialized into a full text article to
be discussed in detail [13].
The analysis of the duct in our study was done
using Q offline analysis (which included MPR
mode and cropping) and gated color flow across
the duct. Used in all feasible cases, the MPR mode
measured the pulmonary end of the duct, and
adequately visualized the duct from the supraster-
nal or the left infra-clavicular view.
We postulate that RT3DE might be measuring
the pulmonary end from different angles than
those measured by angiography and 2D echo.
When we compared 2D echo with angiography
for pulmonary end measurements, there were
good correlations and insignificant differences.
This may be explained by the fact that the pul-
monary ends measured by 2D echo are mostly of
the same dimension measured by angiography
as both have two planes, unlike 3D echo.
In our study, the aortic end of the duct was mea-
sured in a 3D-guided 2D method. This led to
excellent correlation between 3D-guided method
and angiography. There was also good correlation
between 2D echo and angiography in aortic end
measurements. However, the 3D-guided method
was slightly more accurate, efficient and precise
than 2D echocardiography. The aortic end could
not be measured using the MPR mode in a similar
method to the pulmonary end, due to difficulty in
delineating the entire borders of this opening
from the aortic end.
The length of the duct was also measured in a
3D-guided 2D view, where there was good corre-
lation between 2D echo, 3D-guided method, and
angiography with better correlation and less dif-
ference between 3D-guided method and angiog-
raphy compared to 2D echocardiography.
Feasibility may be affected by the echogenicity
and quality of the color flow recorded. Our
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white suppression was adopted from the tech-
nique used by Zakaria in 2009. His study stated
that surgical shunts (modified BT and central
shunts) were much better visualized using the
gated 3D color volumes from origin to insertion
into the pulmonary tree, with demonstration of
the whole extent of the shunt in one image.
According to the Zakaria study, 2D echocardiogra-
phy was able to demonstrate only short segments
from the shunt, and sometimes only the flow into
the pulmonary artery [14].
The comparison and agreement between 2D,
RT3DE, and angiography in determining the ana-
tomical type of the duct were comparable in our
study. Roushdy et al. in 2012 [14] assessed the
accuracy of 3D Echo in the evaluation of PDA in
comparison with 2D Echo and diagnostic angiog-
raphy, and concluded that the agreement between
2D and 3D echocardiography and angiography
was comparable at 85.7% with 2D Echo, and at
84.8% with 3D Echo [14].
Limitations
The main limitation faced during this study was
that our offline analysis may be in need of more
advanced software capabilities than present in
Philips Echo machines, and which are not avail-
able in our center. We do not have a workstation
in our Echo Lab.
Conclusion
Based on our study, real-time three-dimensional
echocardiography (RT3DE) can define the duct
anatomy, length and morphology with accurate
delineation of both aortic and pulmonary ends.
Data obtained from RT3DE were comparable with
those obtained from angiography. This data
helped in the selection of suitable devices for duct
occlusion. The main disadvantage was the time
consumed during data analysis and image
manipulation.
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